A Day Up For Evelo Biosciences, Inc.
Fri, Apr 22, 2022 at 05:30 PM
Evelo Biosciences, Inc. (EVLO:NASDAQ) jumped higher at $2.41, representing a gain of 15.3%. On Thu, Apr 21, 2022, EVLO:NASDAQ touched a New 2-Week Low of $2.09. The stock appeared on our News Catalysts scanner on Thu, Apr 14, 2022 at 06:42 AM in the 'BIOTECH' category. From Thu, Apr 07, 2022, the stock recorded 0.00% Up Days and 10.00% Green Days
About Evelo Biosciences, Inc. (EVLO:NASDAQ)
Evelo Biosciences Inc operates as a bio-technology company. The firm develops therapies for the treatment of the gut-body network. Evelo Biosciences also offers treatment for cancer and inflammatory diseases.
Top 10 Gainers:
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 100.89%
- Blueknight Energy Partners, L.P. (BKEP:NASDAQ), 38.6%
- Moving iMage Technologies Inc. (MITQ:NYSEMKT), 38.26%
- Cyngn Inc. (CYN:NASDAQ), 26.89%
- Sky Harbour Group Corporation Class A (SKYH:NYSEMKT), 26.34%
- Forge Global Holdings Inc. (FRGE:NYSE), 20%
- Syros Pharmaceuticals, Inc. (SYRS:NASDAQ), 18.63%
- DURECT Corporation (DRRX:NASDAQ), 15.59%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 15.31%
- GWG Holdings, Inc. (GWGH:NASDAQ), 15%